Alprazolam
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
67544-415 -
Package NDC
67544-415-15 -
Package NDC
67544-415-20 -
Package NDC
67544-415-30 -
Package NDC
67544-415-45 -
Package NDC
67544-415-53 -
Package NDC
67544-415-55 -
Package NDC
67544-415-60 -
Package NDC
67544-415-70 -
Package NDC
67544-415-75 -
Package NDC
67544-415-80 -
Package NDC
67544-415-92 -
Application number
NDA018276 -
SPL ID
51152b89-539c-4c80-bb84-d7f2dc082953 -
SPL set ID
964d7f43-34a6-45af-a95f-3b9ade17c6a5 -
UNII
YU55MQ3IZY -
RxCUI
197321 -
RxCUI
308047 -
RxCUI
308048
What the source publishes
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Active ingredients
- alprazolam
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA AUTHORIZED GENERIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Alprazolam",
"splId": "51152b89-539c-4c80-bb84-d7f2dc082953",
"labels": [
{
"setId": "964d7f43-34a6-45af-a95f-3b9ade17c6a5",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=964d7f43-34a6-45af-a95f-3b9ade17c6a5",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=964d7f43-34a6-45af-a95f-3b9ade17c6a5"
}
],
"routes": [
"ORAL"
],
"labeler": "Aphena Pharma Solutions - Tennessee, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "15 TABLET in 1 BOTTLE (67544-415-15)",
"package_ndc": "67544-415-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20060510"
},
{
"sample": false,
"description": "20 TABLET in 1 BOTTLE (67544-415-20)",
"package_ndc": "67544-415-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20100426"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (67544-415-30)",
"package_ndc": "67544-415-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20050623"
},
{
"sample": false,
"description": "45 TABLET in 1 BOTTLE (67544-415-45)",
"package_ndc": "67544-415-45",
"identifierStatus": "well-formed",
"marketing_start_date": "20060525"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE (67544-415-53)",
"package_ndc": "67544-415-53",
"identifierStatus": "well-formed",
"marketing_start_date": "20050623"
},
{
"sample": false,
"description": "75 TABLET in 1 BOTTLE (67544-415-55)",
"package_ndc": "67544-415-55",
"identifierStatus": "well-formed",
"marketing_start_date": "20100426"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (67544-415-60)",
"package_ndc": "67544-415-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20050623"
},
{
"sample": false,
"description": "120 TABLET in 1 BOTTLE (67544-415-70)",
"package_ndc": "67544-415-70",
"identifierStatus": "well-formed",
"marketing_start_date": "20050914"
},
{
"sample": false,
"description": "150 TABLET in 1 BOTTLE (67544-415-75)",
"package_ndc": "67544-415-75",
"identifierStatus": "well-formed",
"marketing_start_date": "20060608"
},
{
"sample": false,
"description": "180 TABLET in 1 BOTTLE (67544-415-80)",
"package_ndc": "67544-415-80",
"identifierStatus": "well-formed",
"marketing_start_date": "20060511"
},
{
"sample": false,
"description": "270 TABLET in 1 BOTTLE (67544-415-92)",
"package_ndc": "67544-415-92",
"identifierStatus": "well-formed",
"marketing_start_date": "20100426"
}
],
"productId": "67544-415_51152b89-539c-4c80-bb84-d7f2dc082953",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "67544-415",
"deaSchedule": "CIV",
"genericName": "alprazolam",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ALPRAZOLAM",
"strength": ".5 mg/1"
}
],
"applicationNumber": "NDA018276",
"marketingCategory": "NDA AUTHORIZED GENERIC",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "19811016",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175694",
"M0002356"
],
"unii": [
"YU55MQ3IZY"
],
"rxcui": [
"197321",
"308047",
"308048"
],
"spl_set_id": [
"964d7f43-34a6-45af-a95f-3b9ade17c6a5"
],
"pharm_class_cs": [
"Benzodiazepines [CS]"
],
"pharm_class_epc": [
"Benzodiazepine [EPC]"
],
"manufacturer_name": [
"Aphena Pharma Solutions - Tennessee, LLC"
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:67544-415_51152b89-539c-4c80-bb84-d7f2dc082953"